A new study has revealed that taking weight loss drugs for at least three years could potentially prevent thousands of knee replacements each year.
This finding highlights the possible long-term benefits of GLP-1 medications, which are primarily used for weight management.
As the healthcare community continues to explore innovative solutions for obesity-related issues, this research may influence treatment approaches and patient outcomes.